The multifaceted role of TRAIL signaling in cancer and immunity.

The FEBS Journal
Ludmila Cardoso AlvesPhilippe Krebs

Abstract

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily that can lead to the induction of apoptosis in tumor or infected cells. However, activation of TRAIL signaling may also trigger nonapoptotic pathways in cancer and in nontransformed cells, that is, immune cells. Here, we review the current knowledge on noncanonical TRAIL signaling. The biological outcomes of TRAIL signaling in immune and malignant cells are presented and explained, with a focus on the role of TRAIL for natural killer (NK) cell function. Furthermore, we highlight the technical difficulties in dissecting the precise molecular mechanisms involved in the switch between apoptotic and nonapoptotic TRAIL signaling. Finally, we discuss the consequences thereof for a therapeutic manipulation of TRAIL in cancer and possible approaches to bypass these difficulties.

References

Sep 10, 1993·Cell·L A TartagliaD V Goeddel
May 31, 1996·The Journal of Biological Chemistry·R M PittiA Ashkenazi
Apr 4, 1997·Science·G PanV M Dixit
Jul 10, 1997·Nature·M IrmlerJ Tschopp
Oct 6, 1997·The EMBO Journal·H WalczakC T Rauch
Nov 5, 1997·The Journal of Biological Chemistry·M MacFarlaneE S Alnemri
Nov 5, 1997·Nature Genetics·G S WuW S el-Deiry
Dec 31, 1997·FEBS Letters·P SchneiderJ Tschopp
May 2, 1998·The EMBO Journal·C ScaffidiM E Peter
Jun 11, 1998·The Journal of Biological Chemistry·J G EmeryP R Young
Oct 1, 1998·European Journal of Immunology·M J Martínez-LorenzoA Anel
Apr 20, 1999·The Journal of Experimental Medicine·T S GriffithN A Fanger
Jul 20, 1999·The Journal of Clinical Investigation·A AshkenaziR H Schwall
Mar 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M J KaplanB C Richardson
Mar 23, 2000·Cardiovascular Research·A Saraste, K Pulkki
Feb 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·X D ZhangP Hersey
Apr 27, 2000·Nature Cell Biology·J L BodmerJ Tschopp
Aug 10, 2000·Journal of Virology·P ClarkeK L Tyler
Jan 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·B HilliardY Chen
Mar 30, 2001·The Journal of Biological Chemistry·S E TranJ E Eriksson
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·A K SimonG R Screaton
Apr 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A V FrancoP Hersey
Apr 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S LiuX Cao
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A H ChouP N Hsu
Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·P O VidalainC Servet-Delprat
Oct 5, 2001·The Journal of Biological Chemistry·F C KischkelA Ashkenazi
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·J WangM J Lenardo
Dec 12, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·I MonleónA Anel
Dec 18, 2001·European Journal of Immunology·K SatoK Ogasawara
Jan 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Erika CretneyMark J Smyth

❮ Previous
Next ❯

Citations

Jul 2, 2021·The Journal of Antibiotics·Masami Ishibashi
Aug 24, 2021·Veterinary and Comparative Oncology·Soo-Hyeon KimJung-Hyang Sur
Oct 9, 2021·Signal Transduction and Targeted Therapy·Kai LiYongsheng Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis